PDS appoints Graham Clapperton

pharmafile | January 22, 2010 | Appointment | Research and Development PDS, appointment, research and development 

Pharmaceutical Development Services Ltd (PDS) has appointed Graham Clapperton to head up its quality services.

Graham joins the Nottingham, UK-based consultancy as associate director with responsibility for quality and compliance services.

Graham has 35 years experience in pharmaceutical quality management at industry giant 3M, where for the last twelve years he served as European quality manager.

Advertisement

Michael Gamlen, managing director at PDS, said: “As PDS consultancy and training activities continue to expand at an accelerating pace, it is important that we build a team which is capable of continuing to provide the high level of expertise that our clients have come to expect.

“We make a point of continually monitoring the top people in our areas of expertise, adding them to our team if they become available.”

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …

The Gateway to Local Adoption Series

Latest content